Ronil A. Patel's most recent trade in Opus Genetics Inc. was a trade of 1,282 Common Stock done at an average price of $3.3 . Disclosure was reported to the exchange on Jan. 10, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Opus Genetics Inc. | A. Ronil Patel | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.27 per share. | 10 Jan 2024 | 1,282 | 90,714 | - | 3.3 | 4,186 | Common Stock |
| Opus Genetics Inc. | Patel A. Ronil | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 74,538 | 74,538 | - | - | Employee Stock Option (right to buy) | |
| Opus Genetics Inc. | A. Patel Ronil | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 49,692 | 91,996 | - | 0 | Common Stock | |
| Opus Genetics Inc. | Ronil A. Patel | SVP, Operations & Bus. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
| Opus Genetics Inc. | Ronil A. Patel | SVP, Operations & Bus. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 20,000 | 42,304 | - | 0 | Common Stock |